Cassava Sciences to Hold Corporate Update on November 25th
Cassava Sciences (NASDAQ: SAVA) announced it will host a corporate update via conference call and webcast on Monday, November 25th at 8:00 AM ET. The biotechnology company, which focuses on developing novel Alzheimer's disease treatments, will make the webcast available through their website, with a replay accessible for 90 days following the event on the Company Presentations page.
Cassava Sciences (NASDAQ: SAVA) ha annunciato che ospiter脿 un aggiornamento aziendale tramite conferenza telefonica e webcast il luned矛 25 novembre alle 08:00 ET. L'azienda biotecnologica, che si concentra sullo sviluppo di nuovi trattamenti per la malattia di Alzheimer, render脿 il webcast disponibile attraverso il proprio sito web, e una registrazione potr脿 essere accessibile per 90 giorni dopo l'evento nella pagina delle Presentazioni Aziendali.
Cassava Sciences (NASDAQ: SAVA) anunci贸 que llevar谩 a cabo una actualizaci贸n corporativa a trav茅s de una llamada de conferencia y transmisi贸n web el lunes 25 de noviembre a las 08:00 AM ET. La empresa biotecnol贸gica, que se centra en desarrollar nuevos tratamientos para la enfermedad de Alzheimer, har谩 que la transmisi贸n est茅 disponible a trav茅s de su sitio web, con una repetici贸n accesible durante 90 d铆as despu茅s del evento en la p谩gina de Presentaciones de la Compa帽铆a.
旃挫偓氚� 靷澊鞏胳姢 (NASDAQ: SAVA)電� 11鞗� 25鞚� 鞗旍殧鞚� 鞓れ爠 8:00 ET鞐� 鞝勴檾 須岇潣 氚� 鞗轨簮鞀ろ姼毳� 韱淀暣 旮办梾 鞐呺嵃鞚错姼毳� 歆勴枆頃� 瓴冹澊霛缄碃 氚滍憸頄堨姷雼堧嫟. 鞎岇笭頃橃澊毹鸽硲 旃橂鞝� 臧滊皽鞐� 歆戩頃橂姅 靸濍獏瓿淀暀 須岇偓鞚� 旃挫偓氚旊姅 鞗轨簮鞀ろ姼毳� 鞛愳偓 鞗轨偓鞚错姼毳� 韱淀暣 鞝滉车頃� 鞓堨爼鞚措┌, 鞚措菠韸� 鞚错泟 90鞚� 霃欖晥 須岇偓 頂勲爤鞝犿厡鞚挫厴 韼橃澊歆�鞐愳劀 鞛儩鞚� 臧�電ロ暕雼堧嫟.
Cassava Sciences (NASDAQ: SAVA) a annonc茅 qu'elle tiendra une mise 脿 jour d'entreprise via une conf茅rence t茅l茅phonique et un webinaire le lundi 25 novembre 脿 8h00 ET. L'entreprise biotechnologique, qui se concentre sur le d茅veloppement de nouveaux traitements pour la maladie d'Alzheimer, mettra le webinaire 脿 disposition sur son site web, avec une rediffusion accessible pendant 90 jours apr猫s l'茅v茅nement sur la page des Pr茅sentations de l'Entreprise.
Cassava Sciences (NASDAQ: SAVA) gab bekannt, dass am Montag, den 25. November um 8:00 Uhr ET ein Unternehmensupdate 眉ber eine Telefonkonferenz und Webcast stattfinden wird. Das biotechnologische Unternehmen, das sich auf die Entwicklung neuartiger Behandlungen f眉r die Alzheimer-Krankheit konzentriert, wird den Webcast 眉ber seine Website verf眉gbar machen, mit einer Aufzeichnung, die 90 Tage nach der Veranstaltung auf der Seite Unternehmenspr盲sentationen zug盲nglich ist.
- None.
- None.
Webcast planned for Monday, November 25th at 8:00 AM ET
AUSTIN, Texas, Nov. 24, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA), a clinical-stage biotechnology company focused on developing a novel treatment for Alzheimer鈥檚 disease, today announced it will hold a conference call and webcast on Monday, November 25th at 8:00 a.m. Eastern Time.
| 听 | 听 |
| Event Details: | |
| 听 | 听 |
| Date: | Monday, November 25th |
| Time: | 8:00 a.m. Eastern Time |
| Webcast: | |
| 听 | 听 |
A replay of the audio webcast will also be available on the Company Presentations page of the Cassava Sciences website for 90 days following the webcast.
About Cassava Sciences, Inc.
Cassava Sciences is a clinical-stage biotechnology company based in Austin, Texas. Our mission is to detect and treat neurodegenerative diseases, such as Alzheimer鈥檚 disease.
Simufilam is an investigational oral, small molecule drug candidate currently being evaluated in two Phase 3 clinical trials for the potential treatment of Alzheimer's disease. Simufilam is a proprietary, investigational oral small molecule that targets the filamin A protein. Cassava Sciences owns exclusive, worldwide rights to its investigational product candidates and related technologies, without royalty obligations to any third party.
For more information, please visit:
For More Information Contact:
Investors
Sandya von der Weid
Media
Company
Eric Schoen, Chief Financial Officer
(512) 501-2450
听
FAQ
When is Cassava Sciences (SAVA) holding its corporate update webcast?
How long will the replay of SAVA's November 25th webcast be available?
Where can I access Cassava Sciences' (SAVA) November 25th corporate update webcast?
